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Preoperative, perioperative and postoperative arrhyth•
mias in 52 consecutive patients who underwent operation 
for f:bstein's anorqaJy were reviewed. There were 25 
male and 27 female patients (mean age 18 years, range 
11 months to 64 years). Thirty-four patients had one or 
more documented arrhythmias preoperatively (18 had 
paroxysmal supr;tventricular tachycardia, 10 had par•
oxysmal atrial fibrillation or f1ptter, 13 had ventricular 
arrhythmia and 3 had high grade atrioventricular block). 
Seven patients wi~hout documented arrhythmias had a 
history typical of tachyarrhythPlias. During the peri•
operative and early postoperative periods, 14 patients 
had atrial tachyarr~ythmias and 8 h~d ventricular 
tachycardia or ventricular fibrillation. There were seven 
deaths between day 1 and '21 months after operation. 
Five' of these ~eathli were sudden (all in male patients, 
The pathologic anatomy in Ebsteip.'s anomaly provides the 
substrate for the associated supraventricular and ventricular 
arrhythmias (1,2). In certain patients, these arrhythmias re•
suIt in significant rates of morbidity anf:! mortality, and sud•
den death has been reported (3) in llP to 20% of these 
patients. Associated conditions, Sl!cq 'as accessory atrio•
ventricular (A V) connections, may contribute to these ar•
rhythmias (4,5). Although operative te~hniques have been 
developed that correct or ameliorate tqe underlying struc•
tural and hemodynamic problems, the effect that these pro•
ced4res have postoperatively on supraventricular anq ven•
tricular arrhythmias remains unknown (6-8). This report 
reviews our experience with preoperative, pt;rioperative and 
postoperative cardiac ;lIThyth~ias in patients who underwent 
surgi~al repair of Ebstein's anomaly. 
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aged 12 to 34 years), and four of the patients had had 
perioperative ventricular tachycardia or ventricular fi•
brillation. One patient was takipg one antiarrhythmic 
agent and another patient was taking two at the time of 
sud~en death. 
Of the 18 patients with paroxysmal supraventricular 
tachycardia and 9 patients with paroxysmal atrial fi•
brillation or flutter preoperatively who were followed up 
for a mean of 40 and 36 months, respectively, 22 and 
33% cpntinued to have symptomatic tachycardia. Of tho 
11 patients (mean age 9 years) without pr~operative doc•
umentation or symptoms of arrhythmia, follow-up d~ta 
were obtained (range 1 to 144 months, mean 31) in 9 
pa~ients. None died suddenly or developed symptomatic 
arrhythmia. 
(J Am Coil CardioI1985;6:1351-7) 
Methods 
Patient selection. We reviewed the records of all pa•
tients w~o underwent operation for correction of Ebstein' s 
anomaly between April 1972 and May 1983. In each patient, 
the diagnosis was made by use of cardiac catheterization or 
echocardiography, or both, and was copfirmed at operation. 
Arr~yt}1mias and A V conduction before operation were 
assessed by routine 12 lead electrocardiography in all pa•
tients apd py electrophysiologic study (14 patients), 24 hour 
ambulatory electrocardiographic monitoring (13 patients) 
and treadmill exercise testing (5 p.atients) when clinically 
indicated. All patients hild electrocardiographic monitoring 
intraoperatively and for 3 to 7 days postoperatively. Follow•
up assessment was obtained from data collected by physi•
cians' examinations, health questionnaires or telephone 
interviews. 
Study patients. The 52 patients (25 male and 27 female) 
had a mean age of 18 years (range 11 months to 64 years). 
Forty-six patients (88%) were in New York Heart Associ•
ation functional class III or IV. In addition to the charac•
teristic abnormalities of the tricuspid valve, 45 patients had 
an associat~d atrial septal defect (or defects )-the secundum 
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type in 43, the primum type in 1 and a sinus venosus c!efect 
in 1. Fifteen patients had additional associated cardiac de•
fects (Table 1). Six patients had electrocardiographic evi•
dence of an accessory A V pathway with ventricular pre•
excitation. 
Hemodynamics. Twenty patients underwent preopera•
tive clU'diac catheterization within 1 month of operation. 
The average right atrial and pulmonary artery mean pres•
sures were 9 (range 5 to 14) and 16 (range 12 to 22) mm 
Hg, respectively. Cardiac index ranged from 1.5 to 5.3 
liters/min per m2 (mean 2.7). Forty-four patients had intra•
operative hemodynamic measurements; average pressures 
were: right atrial 9 mm Hg, right ventricular 22/6 mm Hg 
and pulmonary artery 22111 mm Hg. 
Operative technique. The operative technique has been 
described in detail (6) and is based on construction of a 
monocuspid valve by use of the anterior leaflet of the tri•
cuspid valve. Briefly, the repair consists of patch or suture 
closure of an associated atrial septal defect or patent foramen 
ovale; plication of the atrialized portion of the right ventricle; 
"plastic" repair of the tricuspid valve whenever feasible, 
or replacement of the valve; correction of related anomalies 
and excision of redundant right atrial tissue. A plastic repair 
was accomplished in 42 patients, and valve replacement 
with a bioprosthesis was done in 8 patients. The remaining 
two patients who had had a previous Glenn procedure under•
went a modified Fontan-type procedure. In patients with 
accessory A V conduction pathways, e1ectrophysiologic 
mapping and ablation of the pathway were carried out as 
previously described (9). 
Statistical analysis. Comparisons were made by use of 
chi-square analyses. 
Results 
The types of arrhythmia and follow-up data are sum•
marized in Table 2. 
Preoperative arrhythmias. Before operation, 41 (79%) 
of the 52 patients hac! either documented arrhythmias (Pa•
tients 1 to 34) or a history of palpitation, near syncope or 
syncope (Patients 35 to 41). Because of their history of 
palpitation and near syncope or syncope consistent with a 
cardiogenic origin, the latter patients were thought to have 
presumed cardiac arrhythmia. The remaining 11 patients 
(21 %) had no symptoms consistent with, or documentation 
of, an arrhythmia preoperatively. Of 34 patients with 
electrocardiographic documentation of one or more arrhyth•
mias, 18 had paroxysmal supraventricular tachycardia, 10 
had paroxysmal atrial fibrillation or flutter and 13 had ven•
tricular arrhythmias (7 with frequent ventricular premature 
complexes and 6 with nonsustained ventricular tachycardia). 
Three patients had A V block: complete heart block in two 
and second degree (Mobitz type II) A V block in one. Of 
the 13 patients with ventricular arrhythmias, 10 also had 
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Table 1. Cardiac Defects Associated With Ebstein's Anomaly 
in 48 Patients 
Cardiac Defect* 
Atrial septal defect 
Pulmonary stenosis 
Accessory conduction pathways 
Partial anomalous venous return 
Partial A V canal with cleft mitral valve 
Hypoplastic right ventricle 
Absent coronary sinus 
Bilateral superior vena cava 
Hypoplastic pulmonary artery 
Ventricular septal defect 
Sinus of Valsalva aneurysm 
Adhesive pericarditis 
No. of 
Patients 
45 
7 
6 
2 
*Sixty-eight cardiac defects were present 48 patients. Four patients did 
not have any additional defect. AV = atrioventricular. 
other associated rhythm abnormalities (5 had paroxysmal 
supraventricular tachycardia, 4 had paroxysmal atrial fi•
brillation or flutter and 1 had complete heart block). Six of 
the 34 patients were asymptomatic during the arrhythmia 
(Patients 23 and 30 to 34). 
The seven patients without electrocardiographic docu•
mentation of arrhythmia did not have a typical history of 
cardiogenic syncope (Patients 35, 36, 37 and 40) or sus•
tained palpitation (Patients 35 to 41), or both, consistent 
with an arrhythmia. Three patients with syncope had 24 
hour ambulatory or exercise electrocardiographic monitor•
ing. No patient with presumed arrhythmia underwent elec•
trophysiologic study or other evaluations to exclude non•
cardiogenic causes of syncope. Therefore, 35 patients had 
symptomatic arrhythmias preoperatively (28 with docu•
mented arrhythmia and 7 wit/l presumptive arrhythmia). 
The 41 patients with cardiac arrhythmia or symptoms 
compatible with arrhythmia were significantly older than 
the II patients who did not have symptoms or documented 
arrhythmia (mean age 21 versus 9 years, p < 0.01). There 
were no other significant differences in sex, preoperative 
functional class or hemodynamic data between those with 
and without symptoms of preoperative arrhythmia. 
Electrophysiologic studies. Preoperative electrophysi•
ologic assessment was done for 14 patients. Indications were 
palpitation or syncope in 10 patients and electrocardio•
graphic evidence of ventricular pre-excitation in 4 patients. 
At the time of electrophysiologic study, inducible ortho•
dromic reciprocating tachycardia was found in four patients; 
three had inducible sustained atrial flutter or fibrillation, one 
/lad inducible non sustained ventricular tachycardia (5 to 30 
beats in length) and no patient had sustained ventricular 
tachycardia. Dual A V nodal pathway conduction without 
inducible tachycardia was found in one patient. In all four 
patients with ventricular pre-excitation, the accessory A V 
lACC Vol. 6, No.6 
December 1985: 1351-7 
Table 2. Clinical Features and Follow-Up Data in 52 Patients 
Arrhythmia 
Age (yr) 
Patient & Sex Preop Periop 
I 12M PSVT VTIYF, BA 
2 17F PSVT PSVT 
3 IBM PSVT VTIYF 
4 17M PSVTIYT BA 
5 17M PSVT 
6 20F PSVT/WPW PSVT 
7 31M PSVT BA 
8 2M PSVT BA 
9 22F PSVT PSVT 
10 26F PSVTIYT PSVT 
II 28F PSVTIYPCsl 
WPW 
12 IIF PSVT 
13 35M PSVT/WPW PSVTIYT 
14 34F PSVT 
15 24F PSVTIYT 
16 31M PSVT/WPW BA 
17 10M PSVTIYT VT/BA 
18 15F PSVT/WPW PSVT 
19 20M PAF PAF 
20 52F PAF 
21 34M PAF PAFIYT 
22 IF PAF 
23 2M PAF* BA 
24 34M PAFIYPCs 
25 10F PAF BA 
26 9F PAFIYPCs 
27 11M PAFIYT 
28 23F PAFIYPCs 
29 27M BAIYPCs 
30 22M BA' 
31 64M SA' 
32 12M VPCs* VTIYF 
33 26F VPCs* 
34 IOF VI' BA 
35 14M PIS PSVT 
36 18F PIS 
37 I!lF P/S/WPW PAF 
38 24F P 
39 12M P 
40 24F PIS 
41 9M P 
42 9F t BA 
43 1M , BA 
44 16M 
45 2F ~ PSVT , 
46 7F t BA 
47 23F t 
48 9F i' 
49 15F t VF 
50 IF t 
51 2M t 
52 16M t BA 
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Follow-Up 
During Duration 
Hospitalization Status (mo) 
VPCs Sudden death 
Asymptomatic 44 
VTIYF (death) Sudden death (I day) 
PSVT 60 
PSVT 38 
Asymptomatic 84 
Asymptomatic 60 
Asymptomatic 58 
Asymptomatic 63 
PSVT 45 
Asymptomatic 3 
Asymptomatic 
Asymptomatic 12 
PSVT/BA Asymptomatic 48 
VPCs 36 
PSVT 67 
BA 51 
Asymptomatic 3 
Asymptomatic 40 
No follow-up 
VT PAF 14 
PAF 24 
Asymptomatic 44 
PAF Sudden death 5 
Asymptomatic 144 
Asymptomatic 41 
PAF 12 
PM Asymptomatic 
BA BA (pacemaker) 3 
BA BA (pacemaker) 39 
Death Death, MI, (4 days) 
pulmonary embolism 
Sudden death 27 
No follow-up 
Asymptomatic 
Sudden death Sudden death (9 days) 
VTIYF 
Asymptomatic 24 
Asymptomatic 23 
Cardiac tamponade, coma 3 
Asymptomatic 24 
Asymptomatic 36 
VPCs Asymptomatic 60 
Asymptomatic 24 
Death Death (low cardiac output) 
Asymptomatic 12 
Asymptomatic 82 
Asymptomatic 9 
Asymptomatic 5 
No follow-up 
VPCs No fOllow-up 
Asymptomatic 52 
Asymptomatic 46 
VPCs Asymptomatic 35 
*Documented arrhythmia, but no symptoms reported: tno documentation or symptoms of an arrhythmia. BA = bradyarrhythmia: F = female; 
M = male; MI = myocardial infarction; P = palpitation; PAF = paroxysmal atrial fibrillation or flutter; Periop = perioperative; Preop = preoperative; 
PIS = no documented arrhythmia, but palpitation or syncope; PSVT = paroxysmal supraventricular tachycardia; VF = ventricular fibrillation; VPCs 
= ventricular premature complexes; VT = ventricular tachycardia: WPW = Wolff-Parkinson-White syndrome. 
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connection was located in the right ventricular free wall. 
One of these patients had an additional septal pathway, Two 
additional patients with preoperative electrocardiographic 
evidence of ventricular pre-excitation also underwent intra•
operative mapping, and a right ventricular free wall bypass 
connection was identified in each, 
Perioperative arrhythmias. Eleven patients (Patients 
2,6, 9, 10, 13, 18, 19,21, 35, 37 and 45) developed a 
supraventricular tachyarrhythmia (paroxysmal supraventric•
ular tachycardia in eight and paroxysmal atrial fibrillation 
or flutter in three patients) during the induction of anesthesia 
or the preparation for cardiopulmonary bypass. Nine of them 
had a history of preoperative tachycardia or palpitation. The 
arrhythmias were managed by rapid establishment of car•
diopulmonary bypass or electrical conversion to normal si•
nus rhythm. 
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Ventricular tachycardia or ventricular fibrillation oc•
curred in seven patients (Patients 1,3, 13, 17,21,32 and 
49): one during thoracotomy, two during intraoperative epi•
cardial mapping and four after the termination of the pro•
cedure when the patient was off bypass and was normo•
thermic. Only two of these seven patients with ventricular 
tachycardia or ventricular fibrillation (Patients 17 and 32) 
had had preoperative ventricular arrhythmia (Table 3). No 
clinical characteristic (age, functional class, hemodynamics, 
surgical procedure or associated cardiac defects) except sex 
distinguished the patients with peri operative ventricular 
arrhythmias from those without these arrhythmias (more 
male than female patients had peri operative ventricular 
arrhythmias) . 
Twelve patients developed bradyarrhythmias (junctional 
escape rhythm associated with sinus bradycardia in 2 pa-
Table 3. Profile of Nine Patients With Perioperative Ventricular Irritability or Sudden Death, or Both 
Arrhythmia Follow-Up 
Age (yr) Postop in Duration 
Patient & Sex Preop Periop Hospital Operation Status (mo) Medications 
12M PSVT VTIVF VPCs Plastic repair; ASD SD Digitalis, 
closure; multiple dyazide 
DC shocks 
3 IBM PSVT VTIVF VTIVF Plastic repair; ASD SD (1 day) None 
closure; EPS 
24 34M PAF * PAF Plastic repair; ASD SD 6 Procainamide, 
closure; multiple digitalis 
DC shocks 
32 12M VPCs VTIVF Tricuspid valve SD 27 Digitalis 
replacement; 
pulmonary valve 
dilation; ASD 
closure; multiple 
DC shocks 
35 14M PSVT PSVT VTIVF Plastic repair SD (9 days) Lidocaine, 
(2nd day procainamide 
postop) 
13 35M PSVT PSVTIVT Tricuspid valve Asymptomatic 12 None 
replacement; ASD 
closure; repair of 
partial anomalous 
venous return; 
ablation of bypass 
connection 
17 10M PSVTIVT VT Plastic repair; ASD BA 51 Quinidine 
with closure; EPS for 3 mo 
EPS 
21 34M PAF PAFIVF VT Plastic repair; ASD PAF 14 None 
closure; DC 
shock 
49 15F VF VPCs Modified Fontan; No follow-up None 
ASD closure; 
closure of left 
subclavian artery 
*Difficult to restore sinus rhythm. ASD = atrial septal defect; DC = direct current; EPS = electrophysiologic study; Postop = postoperative; 
SD = sudden death; VF = ventricular fibrillation; other abbreviations as in Table 2. 
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tients or high grade A V block in 10 patients) at the termi•
nation of the procedure, which made temporary epicardial 
pacing necessary. 
Early postoperative arrhythmias during hospitaliza•
tion. Supraventricular tachyarrhythmia occurred in only three 
patients, Ventricular arrhythmias were seen in seven pa•
tients: four had frequent ventricular premature complexes 
(Patients 1,41,49 and 52), one had nonsustained ventricular 
tachycardia (Patient 21) and two had ventricular tachycardia 
or fibrillation (Patients 3 and 35), Two patients with ven•
tricular fibrillation died suddenly despite immediate cardiac 
resuscitation: Patient 3 on the first postoperative day and 
Patient 35 on the ninth, Patient 3 also had perioperative 
ventricular tachycardia, and Patient 35 was receiving pro•
cainamide intravenously at the time of sudden death. Both 
patients had normal electrolyte and hemodynamic values 
before sudden death. All 12 patients with junctional rhythm 
or intermittent A V block immediately after operation re•
gained sinus rhythm with normal A V conduction by the 
third postoperative day. 
There were two postoperative deaths not related to ar•
rhythmia. One death (Patient 43) was due to persistent low 
cardiac output. The other (Patient 31) was due to pulmonary 
embolism and myocardial infarction. 
Long-term follow-up. Follow-up assessment was avail•
able for 44 of the 48 patients who survived the operation 
and perioperative period. The mean follow-up period was 
33 months (range 1 to 144). During this time, there were 
three additional deaths (Patients 1, 24 and 32 at 1, 5 and 
27 months, respectively). All deaths were sudden and be•
lieved to be related to cardiac arrrhythmias. Patient 24 was 
still taking oral procainamide at the time of sudden death. 
Postmortem examination of each of these three patients did 
not reveal any structural abnormalities of the heart that would 
account for the sudden death. Two of the three patients with 
late death (Patients I and 32) were noted to have had peri•
operative ventricular tachycardia, and the third patient (Pa•
tient 24) had had bradycardia immediately after operation 
and had a slow restoration of normal sinus rhythm. Eleven 
of the remaining 41 patients continued to have symptomatic 
arrhythmias (4 had paroxysmal supraventricular tachycar•
dia, 3 had paroxysmal atrial fibrillation, 1 had ventricular 
premature complexes and 2 had bradycardia), but 30 patients 
reported no symptoms of arrhythmia. 
Follow-up of patients with preoperative supraven•
tricular tachyarrhythmia. Of 18 patients with docu•
mented preoperative paroxysmal supraventricular tachycar•
dia followed up for a mean of 40 months, 10 (56%) have 
had no further episodes of palpitation, syncope or near syn•
cope. Two (Patients 1 and 3) died suddenly, four (22%) 
continued to have symptomatic tachycardia and two devel•
oped bradycardia (one had sinus arrest and was treated with 
permanent pacemaker implantation and one had asympto•
matic intermittent second degree A V block). 
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Of the nine patients with preoperative atrial flutter or 
atrial fibrillation who were followed up for as long as 144 
months (mean 36), one (Patient 24) died suddenly at 5 
months while still receiving procainamide and digoxin ther•
apy. Of the remaining eight patients, five (55%) have had 
no further symptomatic arrhythmia and three (33%) contin•
ued to have paroxysmal atrial flutter and fibrillation. 
All six patients (Patients 6, 11, 13, 16, 18 and 37) with 
the Wolff-Parkinson-White syndrome had ablation of the 
right-sided accessory A V pathway. During follow-up study 
(mean 32 months, range 3 to 84), only one patient (Patient 
16) continued to have paroxysmal supraventricular tachy•
cardia, but he was considerably less symptomatic than 
preoperatively. 
Follow-up of patients with preoperative ventricular 
arrhythmias. Of the 13 patients with preoperative ven•
tricular arrhythmias, 2 died suddenly during the follow-up 
period. One patient (Patient 32) who developed perioper•
ative ventricular tachycardia died suddenly at 27 months 
postoperatively while receiving digoxin therapy, and the 
other (Patient 24), who also had preoperative paroxysmal 
atrial fibrillation, died at 6 months postoperatively while 
receiving procainamide and digoxin therapy. 
Follow-up of patients with no documented preoper•
ative arrhythmias. Of the 18 patients (11 with and 7 with•
out symptoms) with no documented preoperative arrhyth•
mia, 2 were lost to follow-up study (mean follow-up for the 
remaining 16 patients was 31 months). There were two 
perioperative deaths (Patients 35 and 43): one from low 
cardiac output and one from ventricular tachycardia or fi•
brillation. One patient (Patient 38) had a cardiac arrest sec•
ondary to cardiac tamponade 3 months postoperatively. She 
was successfully resuscitated, but remained in a coma. The 
remaining 13 patients are free of symptoms from arrhythmia. 
Discussion 
In the absence of associated cardiac defects (other than 
atrial septal defects), 70% of infants with Ebstein's anomaly 
survive the first 2 years and 50% survive to 13 years of age 
(10). If a patient survives the early years of life, his or her 
heart may remain stable for a variable period of time (11), 
or it may begin to decompensate slowly and the patient will 
develop significant tricuspid regurgitation and congestive 
heart failure. Sudden death has been observed in up to 20% 
of patients, generally in older children and adults (3). 
Role of cardiac arrhythmias in postoperative course. 
Although surgical treatment for Ebstein' s anomaly improves 
the functional status of the patient, cardiac arrhythmias con•
tinue to be a therapeutic problem and may account for sud•
den death postoperatively (6-8). In this series of 52 con•
secutive patients, there were 7 postoperative deaths (13%) 
during the follow-up interval (mean 33 months). Five of the 
seven deaths most likely were caused by cardiac arrhythmias 
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that occurred between I day and 27 months after surgery 
(Table 3). All patients who died suddenly were male (mean 
age at death 18 years, range 12 to 34). Although all had 
had symptomatic arrhythmias preoperatively, there was no 
significant correlation between preoperative ventricular ar•
rhythmias and postoperative sudden death. However, four 
of the five patients with sudden death had had perioperative 
ventricular tachycardia or ventricular fibrillation (three dur•
ing operation and one on the second postoperative day). 
There were no electrolyte or hemodynamic abnormalities 
that were responsible for these ventricular arrhythmias. There 
were four other patients (Patients 13, 17, 21 and 49) who 
had perioperative ventricular tachycardia or fibrillation (Ta•
ble 3). One patient was lost to follow-up, and the three other 
patients are doing well without antiarrhythmic medication. 
Thus, four (50%) of eight patients who had perioperative 
ventricular tachycardia or fibrillation died suddenly. 
Role of antiarrhythmic therapy. It appears that pa•
tients with Ebstein's anomaly who demonstrate unusllal ven•
tricular irritability during surgical manipulation and the im•
mediate postoperative period are more likely to have sudden 
arrhythmic death. Because of our early experience, it has 
been our practice since 1978 to administer intravenous lido•
caine prophylactically to all patients during the first 48 hours 
after operation and then change to oral procainamide 
(250 to 750 mg, four times/day) for 3 months. However, 
antiarrhythmic agents may aggravate arrhythmias in selected 
patients (12), and the routine use of antiarrhythmic therapy 
in patients undergoing operation for Ebstein's anomaly re•
mains to be evaluated. Two patients (Patients 24 and 35) 
were receiving one or two antiarrhythmic agents at the time 
of sudden death. Whether this was caused by drug failure 
or possibly the result of paradoxic proarrhythymogenic ef•
fect is unknown. Selected patients who have perioperative 
ventricular arrhythmias might benefit from postoperative 
electrophysiologic studies to identify those at risk for sudden 
death and aid in the selection of the optimal drug regimen 
(13-15). 
Role of surgical repair. The surgical repair of Ebstein' s 
anomaly that included closure of atrial septal defect or de•
fects and resection of redundant right atrial tissue did not 
abolish all atrial arrhythmias. However, less than one-third 
of patients with preoperative paroxysmal supraventricular 
tachycardia and paroxysmal atrial fibrillation or flutter con•
tinued to have symptomatic tachycardia during the follow•
up period (mean 3 years). The ablation of accessory A V 
connections eliminated tachyarrhythmia in five of six pa•
tients with W olff-Parkinson-White syndrome. 
The patients who had no preoperative tachyarrhythmias 
or symptoms were considerably younger than the other pa•
tients and rarely developed tachyarrhythmias postopera•
tively. It may be that long-term hemodynamic abnormalities 
due to the intrinsic malformation make older patients with 
Ebstein's anomaly more likely to develop serious cardiac 
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arrhythmias. Successful surgical repair performed before the 
onset of arrhythmias may be effective in interrupting this 
sequence of events. 
Limitations of study. This study has the limitations in•
herent in a retrospective study. Evaluation and monitoring 
of arrhythmias in the preoperative, perioperative and post•
operative periods were variable, so that the incidence of 
arrhythmias may have been underestimated. This shortcom•
ing was due to the fact that some of the techniques for 
detecting arrhythmias were not readily available in the early 
1970s and that each patient was evaluated by a different 
cardiologist. 
Conclusions. Various supraventricular and ventricular 
arrhythmias are common in patients with Ebstein' s anomaly. 
I) The patients with Ebstein' s anomaly who had no pre•
operative tachyarrhythmias were younger than the other pa•
tients and rarely developed tachyarrhythmias or sudden death 
postoperatively. 2) Less than one-third of patients with pre•
operatively documented supraventricular tachyarrhythmias 
continued to have symptomatic arrhythmias after surgical 
repair of Ebstein' s anomaly. 3) Patients with surgical repair 
of Ebstein's anomaly who demonstrated perioperative ven•
tricular tachycardia or fibrillation were at increased risk of 
sudden death. 
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